Cargando…

Building toward useful SARS-CoV-2 models in Africa

Detalles Bibliográficos
Autores principales:	Archibong, Belinda, Metcalf, C. Jessica E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346911/ https://www.ncbi.nlm.nih.gov/pubmed/34321358 http://dx.doi.org/10.1073/pnas.2110873118

Ejemplares similares

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

Africa’s contribution to the science of the COVID-19/SARS-CoV-2 pandemic
por: Kana, Musa Abubakar, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?
por: Lu, Lu, et al.
Publicado: (2021)

SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
por: Drain, Paul K., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

In SARS-CoV-2, astrocytes are in it for the long haul
por: Huang, Shuhan, et al.
Publicado: (2022)

Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2
por: Bleasel, Martin D., et al.
Publicado: (2020)

Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)

Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread
por: Brufsky, Adam
Publicado: (2020)

Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak
por: Metcalf, C. Jessica E., et al.
Publicado: (2020)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

SARS-CoV-2 and human reproduction: An open question
por: Entezami, Frida, et al.
Publicado: (2020)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

Evolutionary medical insights into the SARS-CoV-2 pandemic
por: Crespi, Bernard
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

SARS-CoV-2 and the skin, a hidden treasure
por: Gianotti, Raffaele
Publicado: (2020)

Preventing the introduction of SARS-CoV-2 into school settings
por: Thampi, Nisha, et al.
Publicado: (2021)

The sound of host-SARS-CoV-2 molecular interactions
por: de la Fuente, José, et al.
Publicado: (2021)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Commentary: SARS-CoV-2 in tears: It really matters
por: Biswas, Jyotirmay, et al.
Publicado: (2021)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Convergent evolution of SARS-CoV-2 in human and animals
por: Zhou, Hang-Yu, et al.
Publicado: (2021)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lstpph0cnlu1sestsg17d9vvnd